# Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer

> **NCT04197141** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 58 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Conventionally-fractionated WPRT
- **RADIATION:** Hypofractionated WPRT

## Key facts

- **NCT ID:** NCT04197141
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-02-07
- **Primary completion:** 2024-03
- **Final completion:** 2027-03
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2023-08-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04197141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04197141, "Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04197141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*